A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model

Authors

Chang Li, University of Washington
Anna K Anderson, University of Washington
Peter Ruminski, Washington University School of Medicine in St. Louis
Michael Rettig, Washington University School of Medicine in St. Louis
Darja Karpova, Washington University School of Medicine in St. Louis
Hans-Peter Kiem, Fred Hutchinson Cancer Research Center
John F DiPersio, Washington University School of Medicine in St. Louis
André Lieber, University of Washington

Journal

Blood Advances

Publication Date

8-13-2024

Volume

8

Issue

15

First Page

4089

Last Page

4101

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2024012757

Rights and Permissions

Li C, Anderson AK, Ruminski P, Rettig M, Karpova D, Kiem HP, DiPersio JF, Lieber A. A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood Adv. 2024 Aug 13;8(15):4089-4101. doi: 10.1182/bloodadvances.2024012757. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Li, Chang; Anderson, Anna K; Ruminski, Peter; Rettig, Michael; Karpova, Darja; Kiem, Hans-Peter; DiPersio, John F; and Lieber, André, "A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model." Blood Advances. 8, 15. 4089 - 4101. (2024).
https://digitalcommons.wustl.edu/oa_4/4060

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.